Exercise or conversion by Wright Christopher I of 373 shares of Alkermes Plc subject to Rule 16b-3
ALKS Stock | USD 29.04 0.29 1.01% |
Slightly above 60% of all Alkermes Plc's private investors are looking to take a long position. The analysis of the overall investor sentiment regarding Alkermes Plc suggests that some traders are interested. Alkermes Plc's investing sentiment can be driven by a variety of factors including economic data, Alkermes Plc's earnings reports, geopolitical events, and overall market trends.
Alkermes |
Filed transaction by Alkermes Plc director. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Read at macroaxis.com
Cash Flow Correlation
Alkermes Plc's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Alkermes Plc's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.Click cells to compare fundamentals
Alkermes Plc Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Alkermes Plc can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Alkermes Plc Historical Investor Sentiment
Investor biases related to Alkermes Plc's public news can be used to forecast risks associated with an investment in Alkermes. The trend in average sentiment can be used to explain how an investor holding Alkermes can time the market purely based on public headlines and social activities around Alkermes Plc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Alkermes Plc's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Alkermes Plc and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Alkermes Plc news discussions. The higher the estimate score, the more favorable the investor's outlook on Alkermes Plc.
Alkermes Plc Maximum Pain Price Across January 17th 2025 Option Contracts
Alkermes Plc's options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Alkermes Plc close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Alkermes Plc's options.
Alkermes Plc Fundamental Analysis
We analyze Alkermes Plc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alkermes Plc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alkermes Plc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Market Capitalization
Market Capitalization Comparative Analysis
Alkermes Plc is currently under evaluation in market capitalization category among its peers. Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
Alkermes Plc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Alkermes Plc stock to make a market-neutral strategy. Peer analysis of Alkermes Plc could also be used in its relative valuation, which is a method of valuing Alkermes Plc by comparing valuation metrics with similar companies.
Peers
Alkermes Plc Related Equities
IRWD | Ironwood Pharmaceuticals | 4.16 | ||||
EOLS | Evolus | 3.78 | ||||
COLL | Collegium Pharmaceutical | 3.07 | ||||
PCRX | Pacira BioSciences, | 0.38 | ||||
DVAX | Dynavax Technologies | 0.31 | ||||
NBIX | Neurocrine Biosciences | 0.17 | ||||
ANIP | ANI Pharmaceuticals | 0.11 | ||||
AMPH | Amphastar | 0.17 | ||||
ITCI | Intracellular | 0.62 | ||||
PAHC | Phibro Animal | 1.01 | ||||
PBH | Prestige Brand | 1.08 | ||||
RDY | Dr Reddys | 1.47 |
Additional Tools for Alkermes Stock Analysis
When running Alkermes Plc's price analysis, check to measure Alkermes Plc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alkermes Plc is operating at the current time. Most of Alkermes Plc's value examination focuses on studying past and present price action to predict the probability of Alkermes Plc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alkermes Plc's price. Additionally, you may evaluate how the addition of Alkermes Plc to your portfolios can decrease your overall portfolio volatility.